Group One Trading, L.P. Rubius Therapeutics, Inc. Transaction History

Group One Trading, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.14 - $0.31 $0 - $0	-1 Reduced 0.01%	9,920 $1,000
Q3 2022 Nov 09, 2022	SELL	$0.46 - $1.29 $11,475 - $32,180	-24,946 Reduced 71.55%	9,921 $4,000
Q2 2022 Aug 11, 2022	BUY	$0.79 - $5.98 $3,185 - $24,111	4,032 Added 13.08%	34,867 $30,000
Q1 2022 May 12, 2022	BUY	$4.25 - $10.4 $126,123 - $308,630	29,676 Added 2560.48%	30,835 $170,000
Q4 2021 Feb 11, 2022	BUY	$9.68 - $17.74 $11,219 - $20,560	1,159 New	1,159 $11,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.